Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation
Cancers - Switzerland
doi 10.3390/cancers11030365
Full Text
Open PDFAbstract
Available in full text
Date
March 15, 2019
Authors
Publisher
MDPI AG